Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

Circadian Rhythm and Melatonin in the Treatment of Depression

Author(s): Senthil Kumaran Satyanarayanan, Huanxing Su, Yi-Wen Lin and Kuan-Pin Su*

Volume 24 , Issue 22 , 2018

Page: [2549 - 2555] Pages: 7

DOI: 10.2174/1381612824666180803112304

Price: $65

Abstract

Background: Circadian rhythm disruption underlies the pathophysiology of psychiatric disorders, especially depression. Both pharmacological and non-pharmacological strategies affecting endogenous circadian rhythms have been developed with specificity to alter the circadian dysfunction. The current management strategy with antidepressants is far from being satisfactory in addressing this issue. In recent years, attempts at discovering new antidepressants focused on a melatonergic system which is known to be altered in depression have led to a potential option for treatment of depression.

Methods: We reviewed all recently published relevant articles on melatonin and its analogues to look for their implication in the treatment of circadian rhythm disruption and depression.

Results: Melatonin, a pleiotropic regulator molecule and its analogues (ramelteon, agomelatine, TIK-301, Neu- P11 and tasimelteon) have been observed to resynchronize the circadian rhythm and some were said to alleviate depressive symptoms in depressed subjects.

Conclusion: This review focuses on substantial advances in the melatonin-based chronobiologic intervention and its responses in the treatment of depression.

Keywords: Circadian rhythm, depression, melatonin, melatonin receptor agonists, pharmacology, antidepressants.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy